Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies

Targeting concomitantly cholinesterase (ChEs) and monoamine oxidases (MAO-A and MAO-B) is a key strategy to treat multifactorial Alzheimer's disease (AD). Moreover, it is reported that the expression of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) is increased significantly in the brain of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Muhammad Aamir, Bibi, Saba, Jan, Muhammad Saeed, Ikram, Muhammad, Zaidi, Asma, Farooq, Umar, Sadiq, Abdul, Rashid, Umer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366597/
https://www.ncbi.nlm.nih.gov/pubmed/36105972
http://dx.doi.org/10.1039/d2ra04183a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366597/
https://www.ncbi.nlm.nih.gov/pubmed/36105972
http://dx.doi.org/10.1039/d2ra04183a

Ejemplares similares